Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation

被引:26
作者
Bakker, Sjoerd F. [1 ]
Dik, Vincent K. [2 ]
Witte, Birgit I. [3 ]
Lips, Paul [4 ]
Roos, Jan C. [5 ]
Van Bodegraven, Adriaan A. [1 ]
机构
[1] Vrije Univ Amsterdam, Dept Gastroenterol & Hepatol, Med Ctr, Amsterdam, Netherlands
[2] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[3] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Dept Internal Med, Med Ctr, Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Dept Radiol, Med Ctr, Amsterdam, Netherlands
关键词
Crohn's disease; Osteoporosis; Osteopenia; Bone mineral density; INFLAMMATORY-BOWEL-DISEASE; CONTROLLED-TRIAL; SODIUM-FLUORIDE; RISK-FACTORS; OSTEOPOROSIS; PREVENTION; PREVALENCE; METABOLISM; THERAPY;
D O I
10.1016/j.crohns.2012.06.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims: Decreased bone mineral density (BMD) is common in Crohn's disease (CD) patients. This paper reports on the prevalence of decreased BMD in a referral cohort study of CD-patients next to the change of BMD over time in relation with CD-associated clinical characteristics. Methods: 205 CD patients of a referral hospital were enrolled between januari 1998-January 2010 when measurement of BMD by dual X-ray absorptiometry (DXA) was available. Follow-up DXA scan was performed in subjects with known risk factors besides Crohn indicative for low BMD. Treatment of CD patients was according to a protocol which is comparable to the current (inter)national guidelines. In osteopenic patients, supplemental vitamin D (800 IU) and Calcium (500-1000 mg) were prescribed. Results: Mean BMD at baseline was 0.97 +/- 0.16 gram/cm(2) in lumbar spine and 0.87 +/- 0.12 gram/cm(2) in the total hip. At baseline, higher age and low Body Mass Index (BMI), were negatively correlated with BMD. Eighty-four patients underwent a second BMD assessment with a median interval period of 4 years (IQR 3-6). A mean annual increase of +0.76% (95%CI: -2.63%; +3.87%) in lumbar spine and +0.43% (95%CI: -2.65%; +1.11%) in total hip was observed. Conclusions: Higher age, male sex, low BMI, and a higher age at diagnosis of CD were associated with low BMD. Follow-up of BMD in CD patients showed a contraintuitive small increase of BMD at lumbar spine and total hip in CD patients only using supplemental vitamin D and calcium next to strict treatment of CD. (C) 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:377 / 384
页数:8
相关论文
共 33 条
  • [1] Osteoporosis in inflammatory bowel disease:: effect of calcium and vitamin D with or without fluoride
    Abitbol, V
    Mary, JY
    Roux, C
    Soulés, JC
    Belaiche, J
    Dupas, JL
    Gendre, JP
    Lerebours, E
    Chaussade, S
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (05) : 919 - 927
  • [2] Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: A case-control cross-sectional study of 113 patients
    Andreassen, H
    Hylander, E
    Rix, M
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (03) : 824 - 828
  • [3] A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease
    Bartram, SA
    Peaston, RT
    Rawlings, DJ
    Francis, RM
    Thompson, NP
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (11-12) : 1121 - 1127
  • [4] Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease
    Bartram, Sarah A.
    Peaston, Robert T.
    Rawlings, David
    Walshaw, David
    Francis, Roger M.
    Thompson, Nick P.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (35) : 5680 - 5686
  • [5] The incidence of fracture among patients with inflammatory dowel disease - A population-based cohort study
    Bernstein, CN
    Blanchard, JF
    Leslie, W
    Wajda, A
    Yu, BN
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (10) : 795 - 799
  • [6] Review article: Osteoporosis and inflammatory bowel disease
    Bernstein, CN
    Leslie, WD
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (09) : 941 - 952
  • [7] A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: A pilot study
    Bernstein, CN
    Seeger, LL
    Anton, PA
    Artinian, L
    Geffrey, S
    Goodman, W
    Belin, TR
    Shanahan, F
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (05) : 777 - 786
  • [8] Bischoff SC, 1997, AM J GASTROENTEROL, V92, P1157
  • [9] CUMMING RG, 1990, CALCIFIED TISSUE INT, V47, P194
  • [10] Longitudinal study of bone mineral density in patients with Crohn's disease
    De Jong, DJ
    Mannaerts, L
    Van Rossum, LGM
    Corstens, FHM
    Naber, AHJ
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (07) : 1355 - 1359